Varelas X - Search Results

1

Verteporfin protects against Th17 cell-mediated EAE independently of YAP inhibition.

Brosinsky P, Leister H, Cheng N, Varelas X, Visekruna A, Luu M. Brosinsky P, et al. Among authors: varelas x. Eur J Immunol. 2022 Sep;52(9):1523-1526. doi: 10.1002/eji.202149564. Epub 2022 Jul 25. Eur J Immunol. 2022. PMID: 35776890 Free article.

2

Yap suppresses T-cell function and infiltration in the tumor microenvironment.

Stampouloglou E, Cheng N, Federico A, Slaby E, Monti S, Szeto GL, Varelas X. Stampouloglou E, et al. Among authors: varelas x. PLoS Biol. 2020 Jan 13;18(1):e3000591. doi: 10.1371/journal.pbio.3000591. eCollection 2020 Jan. PLoS Biol. 2020. PMID: 31929526 Free PMC article.

3

Inactivation of LATS1/2 drives luminal-basal plasticity to initiate basal-like mammary carcinomas.

Kern JG, Tilston-Lunel AM, Federico A, Ning B, Mueller A, Peppler GB, Stampouloglou E, Cheng N, Johnson RL, Lenburg ME, Beane JE, Monti S, Varelas X. Kern JG, et al. Among authors: varelas x. Nat Commun. 2022 Nov 28;13(1):7198. doi: 10.1038/s41467-022-34864-8. Nat Commun. 2022. PMID: 36443313 Free PMC article.

4

The Hippo pathway effectors TAZ/YAP regulate dicer expression and microRNA biogenesis through Let-7.

Chaulk SG, Lattanzi VJ, Hiemer SE, Fahlman RP, Varelas X. Chaulk SG, et al. Among authors: varelas x. J Biol Chem. 2014 Jan 24;289(4):1886-91. doi: 10.1074/jbc.C113.529362. Epub 2013 Dec 9. J Biol Chem. 2014. PMID: 24324261 Free PMC article.

5

The transcriptional regulators TAZ and YAP direct transforming growth factor β-induced tumorigenic phenotypes in breast cancer cells.

Hiemer SE, Szymaniak AD, Varelas X. Hiemer SE, et al. Among authors: varelas x. J Biol Chem. 2014 May 9;289(19):13461-74. doi: 10.1074/jbc.M113.529115. Epub 2014 Mar 19. J Biol Chem. 2014. PMID: 24648515 Free PMC article.

6

Therapeutic Targeting of TAZ and YAP by Dimethyl Fumarate in Systemic Sclerosis Fibrosis.

Toyama T, Looney AP, Baker BM, Stawski L, Haines P, Simms R, Szymaniak AD, Varelas X, Trojanowska M. Toyama T, et al. Among authors: varelas x. J Invest Dermatol. 2018 Jan;138(1):78-88. doi: 10.1016/j.jid.2017.08.024. Epub 2017 Sep 1. J Invest Dermatol. 2018. PMID: 28870693 Free PMC article.

7

Stem cell regulation by the Hippo pathway.

Hiemer SE, Varelas X. Hiemer SE, et al. Among authors: varelas x. Biochim Biophys Acta. 2013 Feb;1830(2):2323-34. doi: 10.1016/j.bbagen.2012.07.005. Epub 2012 Jul 20. Biochim Biophys Acta. 2013. PMID: 22824335 Review.

8

A YAP/TAZ-Regulated Molecular Signature Is Associated with Oral Squamous Cell Carcinoma.

Hiemer SE, Zhang L, Kartha VK, Packer TS, Almershed M, Noonan V, Kukuruzinska M, Bais MV, Monti S, Varelas X. Hiemer SE, et al. Among authors: varelas x. Mol Cancer Res. 2015 Jun;13(6):957-68. doi: 10.1158/1541-7786.MCR-14-0580. Epub 2015 Mar 20. Mol Cancer Res. 2015. PMID: 25794680 Free PMC article.

9

The Hippo pathway effector YAP is an essential regulator of ductal progenitor patterning in the mouse submandibular gland.

Szymaniak AD, Mi R, McCarthy SE, Gower AC, Reynolds TL, Mingueneau M, Kukuruzinska M, Varelas X. Szymaniak AD, et al. Among authors: varelas x. Elife. 2017 May 11;6:e23499. doi: 10.7554/eLife.23499. Elife. 2017. PMID: 28492365 Free PMC article.

10

Altered RNA editing in 3' UTR perturbs microRNA-mediated regulation of oncogenes and tumor-suppressors.

Zhang L, Yang CS, Varelas X, Monti S. Zhang L, et al. Among authors: varelas x. Sci Rep. 2016 Mar 16;6:23226. doi: 10.1038/srep23226. Sci Rep. 2016. PMID: 26980570 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86 results

Search Page

Filters